Calorigenic effect of diiodothyronines in the rat

A Lanni, M Moreno, A Lombardi, F Goglia, A Lanni, M Moreno, A Lombardi, F Goglia

Abstract

1. In hypothyroid rats, we determined the effects of administration of different doses of 3,3',5-triiodo-L-thyronine (T3), 3,3'-diiodo-L-thyronine (3,3'-T2) and 3,5-diiodo-L-thyronine (3,5-T2) ("T2 isomers' refers specifically to these latter two isomers throughout this paper) on resting metabolism (RM) and on the oxidative capacity (measured as cytochrome oxidase activity) of tissues that are metabolically very active. 2. The T2 isomers induced a dose-dependent calorigenic effect when injected I.P. into hypothyroid rats. The increase in RM was already evident at a dose of 2.5 micrograms (100 g body wt)(-1), and the greatest effect was observed at the highest dose, 10 micrograms (100 g body wt)(-1), when RM reached a value not significantly different from that of the euthyroid controls (1.92 +/- 0.08 and 1.93 +/- 0.13 (1 O2) kg(-1) h(-1) for 3,5'-T2, respectively, vs. 2.1 +/- 0.12 (1 O2) kg(-1) h(-1) for euthyroid controls). T3 administration restored RM to normal euthyroid values, even at a dose of 2.5 micrograms (100 g body wt)(-1). 3. The effect of T2 isomers on RM was paralleled by an increase in the oxidative capacity of tissues that are metabolically very active (liver, skeletal muscle, brown adipose tissue (BAT) and heart). The increases were between 33% (liver + 3,3'-T2) and 63% (muscle + 3,3'-T2). By contrast, T3 induced its greatest effect on the liver, with a smaller effect on skeletal muscle, but no significant stimulation in heart and BAT, whatever the dose. 4. These results suggest that T8 isomers might be mediators of the direct thyroid hormone regulation of energy metabolism.

References

    1. J Clin Invest. 1972 Sep;51(9):2493-7
    1. Nature. 1962 Mar 17;193:1058-60
    1. Biol Rev Camb Philos Soc. 1973 Feb;48(1):85-132
    1. J Clin Endocrinol Metab. 1976 Dec;43(6):1203-10
    1. J Clin Invest. 1978 Feb;61(2):459-71
    1. Jpn J Physiol. 1979;29(4):383-92
    1. Biochem J. 1979 Dec 15;184(3):527-38
    1. Endocrinology. 1980 Jun;106(6):1827-36
    1. J Clin Endocrinol Metab. 1980 Jul;51(1):84-9
    1. J Clin Invest. 1982 May;69(5):1176-84
    1. Endocrinology. 1982 Aug;111(2):434-40
    1. Cell Tissue Res. 1982;225(2):427-36
    1. Am J Physiol. 1985 May;248(5 Pt 2):R524-30
    1. Am J Physiol. 1987 Sep;253(3 Pt 1):E255-63
    1. Endocr Rev. 1987 Aug;8(3):288-308
    1. Comp Biochem Physiol B. 1987;88(2):519-22
    1. J Clin Invest. 1988 May;81(5):1476-84
    1. Biochem J. 1989 Aug 1;261(3):945-50
    1. J Physiol. 1990 Dec;431:543-56
    1. Endocrinology. 1992 Feb;130(2):651-6
    1. Mol Cell Endocrinol. 1992 Aug;86(3):143-8
    1. Acta Endocrinol (Copenh). 1992 Dec;127(6):542-6
    1. Pediatr Res. 1994 Jan;35(1):91-5
    1. Am J Physiol. 1994 Apr;266(4 Pt 2):R1371-82
    1. Mol Cell Endocrinol. 1994 Feb;99(1):89-94
    1. FEBS Lett. 1994 Jun 13;346(2-3):295-8
    1. Exp Clin Endocrinol. 1994;102(2):63-89
    1. FEBS Lett. 1994 Sep 5;351(2):237-40
    1. Biochem J. 1994 Sep 15;302 ( Pt 3):857-60
    1. J Mol Endocrinol. 1994 Dec;13(3):275-82
    1. Nature. 1961 Mar 18;189:921-2
    1. J Clin Invest. 1973 Feb;52(2):528-32

Source: PubMed

3
Se inscrever